CIK: 0002103725 · Show all filings
Period: Q4 2025
Filing Date: Feb 5, 2026
Total Value ($000): $106,711 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 900,392 | $71,716 | 67.2% | $65.57 | 0.0% | COM | 76155X100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 189,823 | $16,579 | 15.5% | $81.85 | 0.0% | COM | 74366E102 |
| AVBP | ARRIVENT BIOPHARMA INC | 644,788 | $12,973 | 12.2% | $20.82 | 0.0% | COM | 04272N102 |
| COGT | COGENT BIOSCIENCES INC | 100,000 | $3,552 | 3.3% | $28.11 | 0.0% | COM | 19240Q201 |
| NBP | NOVABRIDGE BIOSCIENCES | 413,979 | $1,648 | 1.5% | $3.98 | — | SPONSORED ADS | 44975P103 |
| KRRO | KORRO BIO INC | 30,265 | $242 | 0.2% | $23.38 | 0.0% | COM | 500946108 |